Xylome is a genetic engineering company with a focus on high-value and sustainable products for drug delivery and personal care. Our patented lead product is Large Lipid Body (LLB) Technology for hydrophobic active pharmaceutical...... Read More
Xylome is a genetic engineering company with a focus on high-value and sustainable products for drug delivery and personal care. Our patented lead product is Large Lipid Body (LLB) Technology for hydrophobic active pharmaceutical ingredients. LLB Technology advances the state-of-the-art for particle-based delivery with significant advantages over liposomes and nanoparticles. GMP samples are available and Xylome is using LLB Techology for the development of a new class of antifungal for serious burns.
As a metabolic engineering company, Xylome has an advanced platform for the expression of fats and oils, which are produced by precision fermentation of our nonconventional yeast. Our available portfolio and GMP samples include multiple forms of YOIL®️, a very pure, bioidentical replacement for RBD-palm oil.
Syntis Bio
Syntis Bio is a clinical-stage biopharmaceutical company developing oral therapies that harness the small intestine’s unique biology to provide more accessible, effective and sustainable solutions across the healthcare spectrum, from rare genetic disorders to...... Read More
Syntis Bio is a clinical-stage biopharmaceutical company developing oral therapies that harness the small intestine’s unique biology to provide more accessible, effective and sustainable solutions across the healthcare spectrum, from rare genetic disorders to the world’s most prevalent conditions. Syntis is rapidly advancing a pipeline of oral therapies engineered for targeted activity in the small intestine, the body’s nexus for metabolic control, digestion and drug absorption. Alongside its lead obesity program, SYNT-101, the company is advancing a portfolio of therapies targeting orphan metabolic diseases and intestinal-related disorders. Syntis is headquartered in Boston, MA.
MITSUBISHI GAS CHEMICAL COMPANY, INC.
Mitsubishi Gas Chemical (MGC) is a leading company in the field of oxygen barrier and absorbing polymers. Based on these technologies and experiences, MGC launched new multilayer plastic vial & syringe named OXYCAPT™ in...... Read More
Mitsubishi Gas Chemical (MGC) is a leading company in the field of oxygen barrier and absorbing polymers. Based on these technologies and experiences, MGC launched new multilayer plastic vial & syringe named OXYCAPT™ in 2019. It has achieved excellent oxygen, carbon dioxide & ultraviolet (UV) barrier, high water vapor barrier, very low extractables, high pH stability, low protein adsorption, high transparency, high break resistance, easier disposability, lighter weight, etc.
OXYCAPT™ consists of three layers. The drug contact layer and the outer layer are made of cyclo-olefin polymer (COP), and the oxygen barrier layer is made of MGC’s novel polyester.
The oxygen & carbon dioxide barrier of OXYCAPT™ vial is about 20 times better than that of COP monolayer vial. OXYCAPT™ also provides an excellent UV barrier. While about 70% of 300 nm UV light transmits through glass and COP, only 1.7% transmits through OXYCAPT™. OXYCAPT™ vial is produced by co-injection blow-molding technology. MGC has also developed inspection methods for testing the oxygen barrier layer. All of the containers are fully inspected by state-of-the-art inspection machinery. MGC can offer ready-to-use (RTU) vials in tray or nest & tub formats. The vials are mainly sterilized using gamma rays. There are 2, 6, 10 and 20 mL variants for vials.
OXYCAPT™ vial is especially suitable for biologics and cell & gene therapy products stored at deep-cold or cryogenic temperature. It can maintain container closure integrity (CCI) under such harsh conditions and prevent carbon dioxide permeation generated from dry ice and nitrogen permeation from liquid nitrogen. As the carbon dioxide permeation usually causes pH shift and nitrogen permeation causes over-pressure in headspace, MGC believes OXYCAPT™ is an ideal solution for the drugs stored in dry ice and liquid nitrogen.
sfm medical devices GmbH
High quality single-use medical devices.
Development, production, and registration – everything from one source for the global medical technology and pharmaceutical industry.
Since the foundation of sfm medical devices GmbH in 1953, we, as...... Read More
High quality single-use medical devices.
Development, production, and registration – everything from one source for the global medical technology and pharmaceutical industry.
Since the foundation of sfm medical devices GmbH in 1953, we, as a company, feel a responsibility to our employees, customers, suppliers, the environment, and society.
Our precision single-use medical devices are used in many areas of human medicine and by the pharmaceutical industry. Numerous controlled manufacturing techniques and close collaboration amongst the different departments and subsidiaries results in outstanding quality. Mastering these collaborative efforts makes sfm unique in the market!
Altek Medical
Altek Medical designs, develops and manufactures medical devices with a global footprint across Taiwan, Singapore, Malaysia and China. Altek provides solutions and services with a proven record of product development and manufacturing, spanning from...... Read More
Altek Medical designs, develops and manufactures medical devices with a global footprint across Taiwan, Singapore, Malaysia and China. Altek provides solutions and services with a proven record of product development and manufacturing, spanning from product design, verification, validation to automated manufacturing. Altek specializes in electromechanical design with a combination of mechanical, electronics, optics and software expertise. Altek’s key products include smart drug delivery devices such as autoinjectors, pen injectors, off-body injectors, on-body injectors, and infusion pump that are enabled with wireless connectivity and other advanced technologies.
CarboHyde
CarboHyde is a private preclinical pharmaceutical company specializing in cyclodextrin-based formulation and synthetic solutions. We actively seek partnerships across pharma, biotech, and related sectors to co-develop or support cyclodextrin-enabled applications, including advanced drug delivery,...... Read More
CarboHyde is a private preclinical pharmaceutical company specializing in cyclodextrin-based formulation and synthetic solutions. We actively seek partnerships across pharma, biotech, and related sectors to co-develop or support cyclodextrin-enabled applications, including advanced drug delivery, gene therapy, and vaccine technologies, as well as rare and neurodegenerative disease programs.
OmniScience
OmniScience is an AI company transforming clinical trials with Vivo, the first agentic AI control tower for clinical development. Built by clinical data scientists, Vivo unifies fragmented data, delivers real-time insights, and reduces manual...... Read More
OmniScience is an AI company transforming clinical trials with Vivo, the first agentic AI control tower for clinical development. Built by clinical data scientists, Vivo unifies fragmented data, delivers real-time insights, and reduces manual work by accelerating decisions, cutting costs, and increasing trial success across biotech, pharma, and life sciences. For more information, please visit www.OmniScience.bio
Satio, Inc.
The SatioPatch™ Platform decentralizes care by Transforming Workflow for diagnostics, drug delivery and biometrics integration.
This adhesive patch platform is being developed for drug and vaccine delivery with a reusable applicator and low-cost disposable...... Read More
The SatioPatch™ Platform decentralizes care by Transforming Workflow for diagnostics, drug delivery and biometrics integration.
This adhesive patch platform is being developed for drug and vaccine delivery with a reusable applicator and low-cost disposable with pressure sensors. The platform is designed to provide stable (through adhesive patch) and controlled (through motors) delivery to match the needs of a wide range of drugs and to improve the experience for chronic disease patients with recurring injections.
Radical innovations in workflow include a remote tele-injection capability (video, biometrics, remote control, go/no-go sensors, EHR transmission) and a fully automated delivery through the intradermal (1ml) or subcutaneous route of administration at Therapeutic Dose levels.
Products not yet approved in US or other territories.
Inventage Lab
Inventage Lab is a clinical-stage South Korean biotech developing long-acting injectables and nucleic acid delivery therapies using its proprietary microfluidics-based platforms, DrugFluidic® and GeneFluidic®. With KGMP-certified facilities and multiple LAI programs in clinical stages,...... Read More
Inventage Lab is a clinical-stage South Korean biotech developing long-acting injectables and nucleic acid delivery therapies using its proprietary microfluidics-based platforms, DrugFluidic® and GeneFluidic®. With KGMP-certified facilities and multiple LAI programs in clinical stages, the company actively seeks global partners for licensing and co-development.
Sartorius BIA Separations
Sartorius BIA Separations is developing best-in-class analytical and preparative chromatographic solutions for Gene Therapy and Vaccines spaces. CIM column, utilized in hundreds of clinical batches, are setting the standard of manufacturing highly complex AAV,...... Read More
Sartorius BIA Separations is developing best-in-class analytical and preparative chromatographic solutions for Gene Therapy and Vaccines spaces. CIM column, utilized in hundreds of clinical batches, are setting the standard of manufacturing highly complex AAV, Adeno, pDNA, mRNA, VLP, Viruses, Viral Vaccines, LNP, Exosomes and bacteriophages products. PATfix in-process LC system with multidetector set-up aims to enhance bioprocess understanding and implies a holistic approach to ensure that quality is built into products by design.
KERN LIEBERS
KERN LIEBERS is a global technology leader for the engineering and production of safety-relevant metal components and hybrid assemblies at over 40 locations around the world. Specialized in tailor made SMART SPRINGS and SMART...... Read More
KERN LIEBERS is a global technology leader for the engineering and production of safety-relevant metal components and hybrid assemblies at over 40 locations around the world. Specialized in tailor made SMART SPRINGS and SMART PARTS for specific drug delivery systems.
SMART SPRINGS - Customized Intelligent Power Packs
Design elements as trigger mechanism for drug administration and enery storage in drug delivery systems.
Global manufacturer for all kind of flat springs, wire springs and wave springs.
SMART PARTS - Individual High Complex Components
Design elements for all kind of safety-relevant functions.
Stamped-bent parts, micro-stamped components, assemblies and laser welded parts.
HCmed Innovations Co., Ltd.
HCmed is a CDMO company focused on inhaled drug-device combination by bringing significant value to pharma partners through a cost efficient and risk minimized pathway with our exclusive drug delivery platform of mesh nebulizers....... Read More
HCmed is a CDMO company focused on inhaled drug-device combination by bringing significant value to pharma partners through a cost efficient and risk minimized pathway with our exclusive drug delivery platform of mesh nebulizers.
Our mission is to create products that are highly integrated for affordable-best-quality.